Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 2,310 | 0 | 0 | 0 | 0 |
| Cost of Goods | 1,800 | 0 | 0 | 0 | 0 |
| Gross Profit | 510 | 0 | 0 | 0 | 0 |
| Operating Expenses | 1,330 | 40 | 110 | 10 | 30 |
| Operating Income | -20 | -40 | -110 | -10 | -30 |
| Interest Expense | 30 | 0 | 0 | 0 | 0 |
| Other Income | 10 | 70 | 110 | 80 | 70 |
| Pre-tax Income | -40 | 30 | 0 | 70 | 40 |
| Income Tax | 0 | 10 | 10 | 20 | 10 |
| Net Income Continuous | -40 | 20 | 0 | 40 | 30 |
| Net Income | $-40 | $20 | $0 | $40 | $30 |
| EBITDA(a) | $30 | $-40 | $-110 | $-10 | $-30 |